HomeNDC LookupRxCUI directory › RxCUI 880853

Psyllium 3400 MG Powder for Oral Suspension [Metamucil] — RxCUI 880853

RxNorm drug concept · Semantic branded drug
RxCUI 880853 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 4 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI880853
Official namePsyllium 3400 MG Powder for Oral Suspension [Metamucil]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asMetamucil 3.4 GM Powder for Oral Suspension; Metamucil 3400 MG Powder for Oral Suspension
FDA products mapped2
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Psyllium: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Psyllium is a fiber laxative used to treat occasional constipation and help you get back to a regular routine. It comes in capsules and oral powders under several brand names. Most...
  • Yes, this one is really important. Always mix the powder into a full 8-ounce glass of water or another liquid, stir it well, and drink it right away before it thickens up. If you s...
  • How do I take the powder correctly? I've heard there's a choking risk.
  • It can, yes. Psyllium can slow down how your body absorbs medicines you take by mouth, which may make them less effective. The simple fix: take any prescription medicine at least 2...
📖 Read our full Psyllium guide →

🕸️ Concept Web — How Psyllium 3400 MG Powder for Oral Suspension [Met... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Psyllium 3400 MG Powder for Oral Suspension [Metamucil] RxCUI 880853

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Psyllium 8928
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Metamucil 6802
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Psyllium Powder for Oral Suspension 1873468
    • Psyllium Oral Powder Product 1295184
    • Psyllium Oral Product 1163578
    • Psyllium Powder for Oral Suspension [Metamucil] 1873470
    • Metamucil Oral Powder Product 1873471
    • Metamucil Oral Product 1185636
    • Powder for Oral Suspension 1540456
    • Oral Powder Product 1294711
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Psyllium 3400 MG Powder for Oral Suspension SCD · 824586
  • Psyllium 3400 MG SCDC · 331385
  • Psyllium Powder for Oral Suspension SCDF · 1873468
  • Psyllium Oral Powder Product SCDG · 1295184
  • Psyllium Oral Product SCDG · 1163578

Brand-Name Concepts

  • Psyllium 3400 MG [Metamucil] SBDC · 572702
  • Psyllium Powder for Oral Suspension [Metamucil] SBDF · 1873470
  • Metamucil Oral Powder Product SBDG · 1873471
  • Metamucil Oral Product SBDG · 1185636
  • Metamucil BN · 6802

📦 FDA Products & Package NDCs

2 products · 4 package NDCs
4 package NDCs map to RxCUI 880853 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
37000-0023-04 30 PACKET in 1 CARTON (37000-023-04) / 12 g in 1 PACKET Metamucil Therapy for Regularity The Procter & Gamble Manufacturing Company 1989-03-31
37000-0023-10 12 g in 1 PACKET (37000-023-10) Metamucil Therapy for Regularity The Procter & Gamble Manufacturing Company 1995-12-15
37000-0024-04 30 PACKET in 1 CARTON (37000-024-04) / 5.8 g in 1 PACKET Metamucil Therapy for regularity The Procter & Gamble Manufacturing Company 1994-12-15
37000-0024-10 5.8 g in 1 PACKET (37000-024-10) Metamucil Therapy for regularity The Procter & Gamble Manufacturing Company 1994-12-15
Observed labelers: The Procter & Gamble Manufacturing Company (4) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.